Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-16679-1, published online 19 July 2022
The original version of this Article contained an error in the Methods section.
“Anaesthesia was maintained according to a BIS value of 40 to 60 with propofol plasma target concentration of 2 to 3 μg/ml and remifentanil plasma target concentration of 4 to 6 ng/ml in PR group, and etomidate plasma target concentration of 4 to 6 μg/ml and remifentanil plasma target concentration of 4 to 6 ng/ml in ER group and ERD group.”
now reads:
“Anaesthesia was maintained according to a BIS value of 40 to 60 with propofol plasma target concentration of 2 to 3 μg/ml and remifentanil plasma target concentration of 4 to 6 ng/ml in PR group, and etomidate plasma target concentration of 0.4 to 0.6 μg/ml and remifentanil plasma target concentration of 4 to 6 ng/ml in ER group and ERD group.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, F., Yang, Z., Zeng, S. et al. Author Correction: Effects of etomidate combined with dexmedetomidine on adrenocortical function in elderly patients: a double-blind randomized controlled trial. Sci Rep 13, 1914 (2023). https://doi.org/10.1038/s41598-023-29104-y
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-023-29104-y